Xgene

Xgene Corporation has focused on enabling core technologies to advance human ability to have our biology work for us. We believe that there are several misunderstandings in the standard paradigms of biological sciences, and that by focusing on establishing corrected concepts and core technologies a new era of medicine will evolve. Our core technologies are 1) cryotronic freezing to maintain cell viability in tissues and small organisms 2) spontaneous cell sorting to create 3-D organ models in the lab 3) a unique fibrosis assay to allow efficient screening of anti-fibrotic compounds, we also offer lead compounds 4) reinterpreted gene control signaling for obtaining predictive profiles for genes of interest and 5) blood vessel (microvasculature) formation in tissues maintained outside the body as a tool for accelerating wound healing and successful grafting of lab synthesized organs. We partner with other businesses needing solutions to problems faced when using conventional technologies. Our more engineering perspective in biology has allowed us to focus on the approach that is most likely to solve the problem at hand. Our vast experience with cell culturing and profile of unique core technologies means that the solution you have been searching for may be now available through Xgene Corporation. Our cryotronic freezing is allowing viable freezing of biological material never before frozen successfully. There are broad applications for this in-demand technology. Likewise, our other platforms are one-of-a-kind solutions that solve problems. For example, cell based assays have been traditionally used for drug screening. Our more advanced 3-D cell assembled assays, such as Accuskin, empower your organization with superior cell based assays, while actually providing assays that will bridge the gap to animal assays, and in some cases may substitute entirely for the use of animal testing. Invite us to present our platforms at your organization today.